Cargando…
MACC-1 antibody target therapy suppresses growth and migration of non-small cell lung cancer
Non-small-cell lung cancer (NSCLC) accounts for ~80% of human lung cancers that result in mortalities worldwide. Metastasis-associated in colon cancer-1 (MACC-1) has been demonstrated to be significantly expressed in cases of NSCLC and promotes tumor cell migration and metastasis through transactiva...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865862/ https://www.ncbi.nlm.nih.gov/pubmed/28944826 http://dx.doi.org/10.3892/mmr.2017.7517 |